| An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues MR Corces, AE Trevino, EG Hamilton, PG Greenside, ... Nature methods 14 (10), 959-962, 2017 | 1862 | 2017 |
| Integrating genomic features for non-invasive early lung cancer detection JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ... Nature 580 (7802), 245-251, 2020 | 476 | 2020 |
| DNA methylation and somatic mutations converge on the cell cycle and define similar evolutionary histories in brain tumors T Mazor, A Pankov, BE Johnson, C Hong, EG Hamilton, RJA Bell, ... Cancer cell 28 (3), 307-317, 2015 | 264 | 2015 |
| Noninvasive early identification of therapeutic benefit from immune checkpoint inhibition BY Nabet, MS Esfahani, EJ Moding, EG Hamilton, JJ Chabon, H Rizvi, ... Cell 183 (2), 363-376. e13, 2020 | 259 | 2020 |
| Convergence of placenta biology and genetic risk for schizophrenia G Ursini, G Punzi, Q Chen, S Marenco, JF Robinson, A Porcelli, ... Nature medicine 24 (6), 792-801, 2018 | 250 | 2018 |
| Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ... Nature biotechnology 39 (12), 1537-1547, 2021 | 192 | 2021 |
| Circulating tumor DNA analysis for detection of minimal residual disease after chemoradiotherapy for localized esophageal cancer TD Azad, AA Chaudhuri, P Fang, Y Qiao, MS Esfahani, JJ Chabon, ... Gastroenterology 158 (3), 494-505. e6, 2020 | 174 | 2020 |
| KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition MS Binkley, YJ Jeon, M Nesselbush, EJ Moding, BY Nabet, D Almanza, ... Cancer discovery 10 (12), 1826-1841, 2020 | 105 | 2020 |
| Inferring gene expression from cell-free DNA fragmentation profiles MS Esfahani, EG Hamilton, M Mehrmohamadi, BY Nabet, SK Alig, ... Nature biotechnology 40 (4), 585-597, 2022 | 91 | 2022 |
| Polybrominated diphenyl ethers (PBDEs) and hydroxylated PBDE metabolites (OH-PBDEs) in maternal and fetal tissues, and associations with fetal cytochrome P450 gene expression AR Zota, SD Mitro, JF Robinson, EG Hamilton, JS Park, E Parry, ... Environment international 112, 269-278, 2018 | 74 | 2018 |
| Human placental cytotrophoblast epigenome dynamics over gestation and alterations in placental disease B Zhang, MY Kim, GN Elliot, Y Zhou, G Zhao, D Li, RF Lowdon, ... Developmental cell 56 (9), 1238-1252. e5, 2021 | 36 | 2021 |
| Genomic profiling of BDE-47 effects on human placental cytotrophoblasts JF Robinson, M Kapidzic, EG Hamilton, H Chen, KW Puckett, Y Zhou, ... Toxicological Sciences 167 (1), 211-226, 2019 | 35 | 2019 |
| Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues JF Robinson, EG Hamilton, J Lam, H Chen, TJ Woodruff Placenta 100, 35-44, 2020 | 27 | 2020 |
| Transcriptional dynamics of cultured human villous cytotrophoblasts JF Robinson, M Kapidzic, M Gormley, K Ona, T Dent, H Seifikar, ... Endocrinology 158 (6), 1581-1594, 2017 | 26 | 2017 |
| A comprehensive circulating tumor DNA assay for detection of translocation and copy-number changes in pediatric sarcomas AT Shah, TD Azad, MR Breese, JJ Chabon, EG Hamilton, K Straessler, ... Molecular cancer therapeutics 20 (10), 2016-2025, 2021 | 19 | 2021 |
| Placental gene expression mediates the interaction between obstetrical history and genetic risk for schizophrenia G Ursini, G Punzi, Q Chen, S Marenco, JF Robinson, A Porcelli, ... bioRxiv, 147207, 2017 | 9 | 2017 |
| Phased variant enrichment for enhanced minimal residual disease detection from cell-free DNA DM Kurtz, J Soo, S Alig, LCT Keh, C Macaulay, MC Jin, F Scherer, ... Blood 134, 552, 2019 | 6 | 2019 |
| Distinct chromatin accessibility profiles of lymphoma subtypes revealed by targeted cell free dna profiling M Mehrmohamadi, MS Esfahani, J Soo, F Scherer, JG Schroers-Martin, ... Blood 132, 672, 2018 | 5 | 2018 |
| Cancer biomarkers: Emerging trends and clinical implications for personalized treatment A Passaro, M Al Bakir, EG Hamilton, M Diehn, F André, S Roy-Chowdhuri, ... Cell 187 (7), 1617-1635, 2024 | 4 | 2024 |
| Leveraging phased variants for personalized minimal residual disease detection in localized non-small cell lung cancer. DM Kurtz, JJ Chabon, B Sworder, L Co Ting Keh, J Soo, S Alig, A Schultz, ... Journal of Clinical Oncology 39 (15_suppl), 8518-8518, 2021 | 3 | 2021 |
